TY - JOUR KW - Clinical Trials as Topic KW - Clofazimine KW - Cohort Studies KW - Dapsone KW - Drug Administration Schedule KW - Ethionamide KW - Female KW - Humans KW - Leprostatic Agents KW - leprosy KW - Male KW - Rifampin AU - Pattyn S R AU - Bourland J AU - Grillone S AU - Groenen G AU - Ghys P AB -

In 1981, 1982 and 1983, 216 multibacillary patients in Anjouan (Comores) and Burundi were treated for 8 weeks with daily rifampicin (600 mg) ethionamide (500 mg) and dapsone (100 mg) or clofazimine (100 mg) followed for 44 weeks by once weekly rifampicin (600 mg) and daily ethionamide (500 mg) and dapsone (100 mg) or clofazimine (100 mg). There were 109 previously untreated patients and 107 patients who had dapsone monotherapy, 16 of whom were infected with proven dapsone resistant Mycobacterium leprae. Clinical and bacteriological results were excellent but hepatotoxicity of this regimen remains a problem. No relapses were observed during a 2 to 6 years (mean: 4.29 years) follow-up period after the end of treatment (upper 95% confidence limit of 0.40 per 100 persons years). It is concluded that multibacillary leprosy can be successfully treated with a regimen of one year duration, but less toxic regimens, more easily applicable in the field, are necessary.

BT - Leprosy review C1 - http://www.ncbi.nlm.nih.gov/pubmed/2671559?dopt=Abstract CN - PATTYN1989 DA - 1989 Jun IS - 2 J2 - Lepr Rev LA - eng N2 -

In 1981, 1982 and 1983, 216 multibacillary patients in Anjouan (Comores) and Burundi were treated for 8 weeks with daily rifampicin (600 mg) ethionamide (500 mg) and dapsone (100 mg) or clofazimine (100 mg) followed for 44 weeks by once weekly rifampicin (600 mg) and daily ethionamide (500 mg) and dapsone (100 mg) or clofazimine (100 mg). There were 109 previously untreated patients and 107 patients who had dapsone monotherapy, 16 of whom were infected with proven dapsone resistant Mycobacterium leprae. Clinical and bacteriological results were excellent but hepatotoxicity of this regimen remains a problem. No relapses were observed during a 2 to 6 years (mean: 4.29 years) follow-up period after the end of treatment (upper 95% confidence limit of 0.40 per 100 persons years). It is concluded that multibacillary leprosy can be successfully treated with a regimen of one year duration, but less toxic regimens, more easily applicable in the field, are necessary.

PY - 1989 SP - 109 EP - 17 T2 - Leprosy review TI - Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year. UR - http://leprev.ilsl.br/pdfs/1989/v60n2/pdf/v60n2a04.pdf VL - 60 SN - 0305-7518 ER -